Literature DB >> 22875612

A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy.

Alessandra Casonato1, Viviana Daidone, Giovanni Barbon, Elena Pontara, Irene Di Pasquale, Lisa Gallinaro, Letizia Marullo, Giorgio Bertorelle.   

Abstract

The impaired capacity of von Willebrand factor to carry factor VIII is identified as type 2N von Willebrand's disease. R854Q is the most common type 2N mutation, and almost the only one identified in Italy. This aim of this study was to ascertain whether R854Q mutations in a cohort of Italian patients with type 2N von Willebrand's disease originated from a single event or recurrent events. Thirteen unrelated Italian families were investigated, analyzing the von Willebrand factor gene haplotype associated with the R854Q mutation. A common haplotype emerged in all the families, extending from single nucleotide polymorphisms rs2166902 to rs216293 over 48.2 kb and including five intragenic markers. This haplotype is infrequent in the healthy Italian population (17% versus 100%, P<0.0001) and each genetic marker within the said haplotype is similarly rare. These data strongly suggest a founder effect, with a single R854Q mutation event being the cause of the type 2N von Willebrand's disease in our cohort of patients. Using DMLE+ software and the mathematical model of Bengtsson and Thomson, it was estimated that the R854Q mutation occurred from 10,000 to 40,000 years ago, which is consistent with the short dimension of the haplotype shared by our patients. Together with the fact that the R854Q mutation seems to be limited to Caucasian populations, these findings suggest that a single mutational event took place after human populations moved from Africa towards Europe.

Entities:  

Mesh:

Year:  2012        PMID: 22875612      PMCID: PMC3533677          DOI: 10.3324/haematol.2012.066019

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  25 in total

1.  Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease.

Authors:  A I Woods; S S Meschengieser; A N Blanco; M J Salviú; C E Farías; A C Kempfer; M A Lazzari
Journal:  Haematologica       Date:  2001-04       Impact factor: 9.941

2.  Population growth of human Y chromosomes: a study of Y chromosome microsatellites.

Authors:  J K Pritchard; M T Seielstad; A Perez-Lezaun; M W Feldman
Journal:  Mol Biol Evol       Date:  1999-12       Impact factor: 16.240

3.  A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction.

Authors:  C Mazurier; J Dieval; S Jorieux; J Delobel; M Goudemand
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

4.  Estimating the age of alleles by use of intraallelic variability.

Authors:  M Slatkin; B Rannala
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

5.  An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.

Authors:  Viviana Daidone; Lisa Gallinaro; Maria Grazia Cattini; Elena Pontara; Antonella Bertomoro; Antonio Pagnan; Alessandra Casonato
Journal:  Haematologica       Date:  2011-03-10       Impact factor: 9.941

6.  Recessive inheritance of von Willebrand's disease type I.

Authors:  J C Eikenboom; P H Reitsma; K M Peerlinck; E Briët
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

7.  Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)--detection of a novel candidate type 2N mutation: C2810T (R854W).

Authors:  D J Bowen; G R Standen; C Mazurier; C Gaucher; A Cumming; S Keeney; J Bidwell
Journal:  Thromb Haemost       Date:  1998-07       Impact factor: 5.249

8.  Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease.

Authors:  P A Kroner; K D Friedman; S A Fahs; J P Scott; R R Montgomery
Journal:  J Biol Chem       Date:  1991-10-15       Impact factor: 5.157

9.  An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.

Authors:  Alessandra Casonato; Francesca Sartorello; Maria Grazia Cattini; Elena Pontara; Carmen Soldera; Antonella Bertomoro; Antonio Girolami
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Identifying carriers of type 2N von Willebrand disease: procedures and significance.

Authors:  A Casonato; E Pontara; F Sartorello; M G Cattini; P Perutelli; A Bertomoro; L Gallinaro; A Pagnan
Journal:  Clin Appl Thromb Hemost       Date:  2007-04       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.